{
    "nct_id": "NCT06765434",
    "title": "The Effects of Personalized Music Listening on Functional and Cognitive Status in Advanced-Stage Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2025-09-20",
    "description_brief": "Recent functional imaging studies have facilitated a better understanding of the neuroplasticity mechanisms underlying the strong and multifaceted effects of music on brain development. For this reason, music is considered a significant factor in improving recall and mood in individuals with dementia.\n\nA review investigating the cognitive and behavioral effects of music listening in Alzheimer's disease (AD) reported that personalized (individualized) music listening yielded the best outcomes.\n\nThis study aims to examine the effects of personalized music activities on functional and cognitive status in individuals with advanced-stage AD.",
    "description_detailed": "N/A",
    "phase": [
        "NA"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": null,
    "target_category": "cognitive enhancer",
    "drug": [],
    "placebo": [],
    "explanation_target": [
        "Reason: The intervention is personalized (individualized) music listening aimed at improving recall, mood, functional and cognitive status in people with advanced Alzheimer's disease. The described mechanism relies on neuroplasticity and memory/emotion engagement (not a pharmacologic or pathology-directed mechanism).",
        "Act: Key extracted details \u2014 Intervention: personalized music listening/playlists; Population: advanced-stage AD; Intended effects: improve cognitive status (recall, episodic/autobiographical memory) and mood/behavior. This is a non\u2011pharmacologic cognitive-stimulation/behavioral therapy rather than a biologic or small molecule. Evidence that personalized music can improve cognition and neuropsychiatric symptoms is reported in randomized and controlled studies and reviews. \ue200cite\ue202turn0search0\ue202turn0search1\ue202turn0search4\ue202turn0search3\ue201",
        "Reflect: The trial does not test a biologic or small-molecule drug, so it cannot be categorized as 'disease-targeted biologic' or 'disease-targeted small molecule.' Because the primary stated outcomes are functional and cognitive status (recall), the best-fit category among the provided options is 'cognitive enhancer.' Note: personalized music also commonly improves mood and neuropsychiatric symptoms (so there is some overlap with 'neuropsychiatric symptom improvement'), but the trial title and aim emphasize cognitive/functional outcomes, supporting classification as 'cognitive enhancer.' \ue200cite\ue202turn0search6\ue202turn0search8\ue201",
        "Web search results supporting the above (selected): 1) Large 6-month study showing individualized music playlists improved neuropsychiatric symptoms, agitation and depression in nursing-home residents with dementia. \ue200cite\ue202turn0search0\ue201 2) A double-blind RCT reporting music therapy enhanced episodic memory in AD and mixed dementia. \ue200cite\ue202turn0search1\ue201 3) Meta-analyses/RCT evidence that music therapy can improve cognition, psychiatric symptoms, and caregiver distress in AD. \ue200cite\ue202turn0search4\ue201 4) A 2022 review summarizing how music interactions bolster memory, emotion, and cognitive stimulation in AD. \ue200cite\ue202turn0search3\ue201"
    ],
    "agent_type": "M) Synaptic Plasticity/Neuroprotection",
    "explanation_agent": [
        "Reason: The intervention is personalized music listening (a non\u2011pharmacologic cognitive\u2011stimulation/behavioral therapy) intended to improve recall, mood and functional/cognitive status by engaging memory, emotion and neuroplasticity rather than by acting on a specific molecular pathology (e.g., amyloid, tau). CADRO categories that address enhancement of synaptic function, plasticity and neuroprotection best capture interventions whose mechanism is to stimulate cognitive networks and plasticity.",
        "Act: Extracted details \u2014 Intervention: personalized music playlists; Population: advanced-stage Alzheimer\u2019s disease; Intended effects: improve episodic/autobiographical recall, cognition and mood. This is not a biologic or small\u2011molecule drug and no drug/target gene or pathway is specified. Mapping to CADRO: assign 'M) Synaptic Plasticity/Neuroprotection' because the stated mechanism (neuroplasticity, memory/emotion engagement, cognitive enhancement) aligns with synaptic\u2011plasticity/neuroprotection targets rather than pathology\u2011directed categories.",
        "Reflect: Confirmed the classification fits the description \u2014 although the trial also affects mood/neuropsychiatric symptoms (which could map to other symptom\u2011focused categories), the primary mechanistic rationale provided is enhancement of memory and neuroplasticity, so 'M) Synaptic Plasticity/Neuroprotection' is the most specific CADRO match. No investigational drug or molecular target was provided; therefore no web search for drug/target was necessary. If you would like, I can run literature searches and provide supporting references for music therapy effects in AD."
    ]
}